The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services 72 - Scientific research and development 72.1 - Research and experimental development on natural sciences and engineering 72.10 - Research and experimental development on natural sciences and engineering
400 jobs Number of planned job losses
Announcement Date
20 September 2017
Employment effect (start)
18 December 2017
Foreseen end date
Description
The Swiss laboratory Galderma (Nestlé group) has announced a plan to reduce or close the R&D activity in its site of Sophia Antipolis (Alpes-Maritimes) where 550 people are employed. The company justifies its decision with the fact that the company is undergoing a reorientation which affects in particular the centre of research in dermatology of Sophia Antipolis. The decision surprised the workforce as in 2014, the company forecasted an extension of 4,500 m² and the recruitment of at least 300 additional employees. The plan, presented to works council, includes a 300 voluntary departures plan and reemployment measures for a hundred of employees in a future R&D centre outside Sophia Antipolis.
Galderma employs a total of 6,000 employees worldwide. According the Les Echos, 'this is the third plan of restructuring at Nestlé since the American activist Daniel Loeb, holder of 1% of the capital, called for a change of strategy in favour of a better remuneration of the shareholders'.
Sources
20 September 2017: L'usine Nouvelle
20 September 2017: Les Echos
Citation
Eurofound (2017), Galderma Research & Development, Internal restructuring in France, factsheet number 92068, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/92068.